Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Cardiovascular Event Prevention in AMI Patients with Prediabetes
NCT05182970Phase 3Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Dec 2021
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in prediabetes, sponsored by Karolinska Institutet. Started Dec 2021; status: recruiting.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05182970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05182970.